Dose-rate constant and air-kerma strength evaluation of a new 125I brachytherapy source using Monte Carlo
DOI:
https://doi.org/10.15392/bjrs.v9i1A.1441Keywords:
brachytherapy, iodine-125, Monte-Carlo method.Abstract
Brachytherapy is a modality of radiotherapy which treats tumors using ionizing radiation with sources located close to the tumor. The sources can be produced from several radionuclides in various formats, such as Iodine‑125 seeds and Iridium‑192 wires. In order to produce a new Iodine‑125 seed in IPEN/CNEN and ensure its quality, it is essential to describe the dosimetry of the seed, so when applied in a treatment the lowest possible dose to neighboring healthy tissues can be reached. The report by the AAPM’s Task Group 43 U1 is a document that indicates the dosimetry procedures in brachytherapy based on physical and geometrical parameters. In this study, dose-rate constant and air-kerma strength parameters were simulated using the Monte Carlo method radiation transport code MCNP4C. The air-kerma strength is obtained from an ideal modeled seed, since its actual value should be measured for seeds individually in a specialized lab with a Wide-Angle Free-Air Chamber (WAFAC). Dose-rate constant and air-kerma strength are parameters that depends on intrinsic characteristics of the source, i.e. geometry, radionuclide, encapsulation, and together they define the dose-rate to the reference point, defined as the dose-rate to a point 1 cm away from the geometric center of the source, in its transverse plane. This study presents the values found for these parameters with associated statistical uncertainty, and is part of a larger project that aims the full dosimetry of this new seed model, including experimental measures.Downloads
References
STEWART, B. W.; WILD, C. P. World Cancer Repost 2014, International Agency for Research on Cancer, Lyon, France, 2014.
ROSTELATO, M. E. C. M. Estudo e Desenvolvimento de uma nova Metodologia para Confecção de Sementes de Iodo-125 para Aplicação em Braquiterapia, Instituto de Pesquisas Energéticas e Nucleares, São Paulo, Brazil, 2006.
NATH, R.; ANDERSON, L. L.; LUXTON, G.; WEAVER, K. A.; WILLIAMSON, J. F.; MEIGOONI, A. S. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43, Med Phys, v. 22, n. 2, p. 209-234, 1995.
RIVARD, M. J.; COURSEY, B. M.; DEWERD, L. A.; HANSON, W. F.; HUQ, M. S.; IBBOTT, G. S.; MITCH, M. G.; NATH, R.; WILLIAMSON, J. F. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations, Med Phys, v. 31, n. 3, p. 633-674, 2004.
BRIESMEISTER, J. F. (ed.), MCNPTM – A General Monte Carlo N-Particle Transport Code Version 4C Manual, Radiation Safety Information Computational Center, Los Alamos, USA, 2000.
BAGHANI, H. R.; LOHRABIAN, V.; AGHAMIRI, M. R.; ROBATJAZI, M. Monte Carlo Determination of Dosimetric Parameters of a New 125I Brachytherapy Source According to AAPM TG-43 (U1) Protocol, Arch Iran Med, v. 19, n. 3, p. 186-191, 2016.
BELOUSOVA, A. V.; KALACHEV, A. A.; OSIPOVB, A. S. Monte Carlo Calculation of Dosimetry Parameters for a Brachytherapy Source, Moscow University Physics Bulletin, v. 69, n. 6, p. 535-541, 2014.
Chart of Nuclides – NNDC – Brookhaven National Laboratory, Available at: . Last accessed: 13 Sept. 2019.
J. KATAKURA, Nuclear Data Sheets for A = 125, Nuclear Data Sheets, 112(3), p. 495 705, 2012.
“Composition of Materials used in STAR Databases”, Available at: Last accessed: 13 Sept. 2020.
Published
Issue
Section
License
Copyright (c) 2021 Brazilian Journal of Radiation Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing: The BJRS articles are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
How to Cite
